Development of an innovative pilot line and its validation under real conditions using synthesis process of a model active pharmaceutical ingredient.
2024-10-12 13:23:31
Development of an innovative pilot line and its validation under real conditions using synthesis process of a model active pharmaceutical ingredient.
Utilisation of a matrix metalloprotease inhibitor to develop an innovative therapeutic method that prevents the development of post-traumatic and post-stroke epilepsy.
Development of the innovative formulation of the combination drug dedicated for the geriatric patients in pain pharmacotherapy
Development of an innovative combined preparation dedicated for the treatment of hypertension.
Establishment of a R&D Laboratory of Super Generic Drugs.